Bedawi Eihab O, Hassan Maged, Rahman Najib M
Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, United Kingdom.
Oxford Respiratory Trials Unit, University of Oxford, Oxford, United Kingdom.
Clin Respir J. 2018 Aug;12(8):2309-2320. doi: 10.1111/crj.12941.
Pleural infection is a condition commonly encountered by the respiratory physician. This review aims to provide the reader with an update on the most recent data regarding the epidemiology, microbiology, and the management of pleural infection.
Medline was searched for articles related to pleural infection using the terms "pleural infection," "empyema," and "parapneumonic." The search was limited to the years 1997-2017. Only human studies and reports in English were included.
A rise in the incidence of pleural infection is seen worldwide. Despite the improvement in healthcare practices, the mortality from pleural infection remains high. The role of oral microflora in the etiology of pleural infection is firmly established. A concise review of the recent insights on the pathogenesis of pleural infections is presented. A particular focus is made on the role of tPA, DNAse and similar substances and their interaction with inflammatory cells and how this affects the pathogenesis and treatment of pleural infection.
Pleural infection is a common disease with significant morbidity and mortality, as well as a considerable economic burden. The role of medical management is expanding thanks to the widespread use of newer treatments.
胸膜感染是呼吸内科医生常遇到的一种病症。本综述旨在为读者提供有关胸膜感染的流行病学、微生物学及治疗方面最新数据的更新情况。
使用“胸膜感染”“脓胸”和“肺炎旁”等术语在Medline数据库中检索与胸膜感染相关的文章。检索限于1997年至2017年。仅纳入英文的人体研究和报告。
全球胸膜感染的发病率呈上升趋势。尽管医疗实践有所改进,但胸膜感染导致的死亡率仍然很高。口腔微生物群在胸膜感染病因中的作用已得到确证。本文对胸膜感染发病机制的最新见解进行了简要综述。特别关注了组织型纤溶酶原激活剂(tPA)、脱氧核糖核酸酶(DNAse)及类似物质的作用,以及它们与炎症细胞的相互作用,及其如何影响胸膜感染的发病机制和治疗。
胸膜感染是一种常见疾病,具有较高的发病率和死亡率,以及相当大的经济负担。由于新型治疗方法的广泛应用,内科治疗的作用正在扩大。